Hookworm infections
Conditions
Interventions
Albendazole Efficacy
albendazole efficacy
Sponsors
Amhara Regional Health Bureau
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? All outpatients agree to comply with study procedures, including the provision of two enough stool samples at the beginning (baseline) and at post-treatment follow up assessments (approximately 2 weeks, later). ? All hookworm positive study participants > 2 years old ? Both sex (female and male ) hookworm positive participants
Exclusion criteria
Exclusion criteria: ? Pregnant women ? Patients undertake anthelminthic drugs during data collection time within the past 6 weeks) ? Participants with medication with known interaction (e.g. for albendazole: cimetidine, praziquantel, and dexamethasone) ? Patients who had a history of severe chronic disease (e.g.cancer, diabetes, chronic heart, liver or renal disease). ? Participants having diarrhea or vomiting
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate and egg reduction rates of single doses of albendazole were the primary outcomes of this study | — |
Secondary
| Measure | Time frame |
|---|---|
| MIC of albendazole killing effects for hookworm larva in culture media | — |
Countries
Ethiopia
Contacts
Public ContactAyalew Jejaw
Department of Medical Parasitology School of Biomedical and Laboratory Sciences College of Medicine and Health sciences University of Gondar
Outcome results
None listed